⌘K

Login Start Free

Home/Filings/4/0000899243-17-012936

4//SEC Filing

Novus Therapeutics, Inc. 4

Accession 0000899243-17-012936

$ELDNCIK 0001404281operating

View on SEC.gov Company Profile

Filed

May 10, 8:00 PM ET

Accepted

May 11, 8:36 PM ET

Size

4.9 KB

Accession

0000899243-17-012936

Insider Transaction Report

Form 4

Period: 2017-05-10

Novus Therapeutics, Inc.NVUS

FLESHER GREGORY J.

DirectorChief Executive Officer

Transactions

Purchase
Common Stock
2017-05-10$9.99/sh+58,959$589,000→ 115,856 total

Footnotes (1)

[F1]All numbers give effect to the 1:9 reverse stock split effected by the Issuer on May 11, 2017.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Novus Therapeutics, Inc.

CIK 0001404281

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001404281

Filing Metadata

Form type: 4
Filed: May 10, 8:00 PM ET
Accepted: May 11, 8:36 PM ET
Size: 4.9 KB

View on SEC.gov